fashion -WSS

fashion

author：entertainment 2025-10-02 11:09:42 - browse：6537

Stock exchange — Drew Angerer/Getty Images

Sage Therapeutics said Monday that it may need to reduce costs, including through employee layoffs, following the Food and Drug Administration’s denial of its rapid-acting drug for major depressive disorder.

On Friday, the agency granted market clearance for the drug, called Zurzuvae, to treat women with postpartum depression, a smaller commercial market. Sage failed to convince regulators to also approve the drug for depression, a broader condition.

“We don’t agree with the FDA review,” Sage CEO Barry Greene said during an earnings call, a point he made repeatedly. “We are evaluating the [FDA’s response letter] and as soon as we can provide more clarity, we will, on what the next steps are.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： New guidelines on severe brain injury complicate already difficult decisions

entertainment

hotspot

WSS

Norman Reedus' Daryl Dixon

Stanford president to resign after investigation of research

WATCH: Why do fingernails fall off when they're damaged?

New warning issued for rebooking air travel after delays, cancellations

New guidelines on severe brain injury complicate already difficult decisions

India sets sights on home

focus

fashion

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

Ebola public health emergency is over, WHO declares

Alkermes shareholders re

WATCH: Why do fingernails fall off when they're damaged?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Ask STAT: What do you want to know about ChatGPT in medicine?

Hepatitis C has a cure — but many Americans still lack access to it

Plane’s emergency slide plummets from sky, hits Chicago home

Alkermes shareholders re

The battle over the Brookhaven Landfill on Long Island

hotspot

Stanford updates investigation of president’s past research

Why are elite athletes different? Take a look at their microbes

Trump got a 'target letter.' What is one and what does it mean?

Cloning humans is technically possible. It's curious no one has tried

Disclosing genetic information: not as worrisome as once feared

Seattle police shoot person suspected in downtown stabbing

hotspot

entertainment

hotspot

hotspot